Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS) (N-Term) Peptide
CMAS
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CMAS products
- CMAS (Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MDSVEKGAAT SVSNPRGRPS RGRPPKLQRN SRGGQGRGVE KPPHLAALIL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- CMAS Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CMAS (Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS))
- Background
-
This gene encodes an enzyme that converts N-acetylneuraminic acid (NeuNAc) to cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-NeuNAc). This process is important in the formation of sialylated glycoprotein and glycolipids. This modification plays a role in cell-cell communications and immune responses. Alternative splicing results in multiple transcript variants.
Alias Symbols: CSS
Protein Size: 434 - Gene ID
- 55907
- NCBI Accession
- NM_018686, NP_061156
- UniProt
- Q8NFW8
-
You are here:
